James Seddon

@jaseddon.bsky.social

Paediatric Infectious Diseases doctor and TBologist

In the endTB trial, researchers assessed the efficacy and safety of five 9-month, all-oral treatment regimens, as compared with the evolving standard of care, in participants with rifampin-resistant, fluoroquinolone-susceptible tuberculosis. nej.md/3WFFJTv #MedSky #IDSky

The New England Journal of Medicine    
Oral Regimens for Rifampin-Resistant Tuberculosis 
A PLAIN LANGUAGE SUMMARY    

Visual representation of a patient with rifampin-resistant tuberculosis. 

Read the full Plain Language Summary at NEJM.org.

A reminder on #WorldChildrensDay that 1.3million children fell ill with #tuberculosis in 2023, causing 200,000 paediatric deaths from a disease that's curable & preventable. Govts & funders must urgently prioritise children in research funding & program implementation. msfaccess.org/tactic-test-...

TACTIC: Test, Avoid, Cure TB in Children

Survey of adoption of WHO paediatric TB guidelines into national policy frameworks in 14 countries

msfaccess.org